Veterinary Medicines Information website

Locatim inj.

Authorised
  • Immunoglobulins against Bovine coronavirus, Bovine
  • Immunoglobulins against Bovine rotavirus, Bovine
  • Immunoglobulins against Escherichia coli F5 antigen, Bovine
  • Immunoglobulins against Escherichia coli 078:80B, Bovine
  • BOVINE ROTAVIRUS IMMUNOGLOBULIN
Download as PDF

Product identification

Medicine name:
Locatim inj.
Active substance:
  • Immunoglobulins against Bovine coronavirus, Bovine
  • Immunoglobulins against Bovine rotavirus, Bovine
  • Immunoglobulins against Escherichia coli F5 antigen, Bovine
  • Immunoglobulins against Escherichia coli 078:80B, Bovine
  • BOVINE ROTAVIRUS IMMUNOGLOBULIN
Target species:
  • Cattle (pre-ruminant)
Route of administration:
  • Oral use
  • Subcutaneous use

Product details

Active substance and strength:
  • Immunoglobulins against Bovine coronavirus, Bovine
    0.00
    enzyme-linked immunosorbent assay unit
    /
    1.00
    millilitre(s)
  • Immunoglobulins against Bovine rotavirus, Bovine
    0.00
    enzyme-linked immunosorbent assay unit
    /
    1.00
    millilitre(s)
  • Immunoglobulins against Escherichia coli F5 antigen, Bovine
    0.00
    enzyme-linked immunosorbent assay unit
    /
    1.00
    millilitre(s)
  • Immunoglobulins against Escherichia coli 078:80B, Bovine
    0.01
    slow agglutination test unit(s)
    /
    1.00
    millilitre(s)
  • BOVINE ROTAVIRUS IMMUNOGLOBULIN
    100.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Oral use
    • Cattle (pre-ruminant)
      • Meat and offal
        0
        day
  • Subcutaneous use
    • Cattle (pre-ruminant)
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AM05
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Germany
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 18 of Regulation (EU) 2019/6)
Marketing authorisation holder:
  • Melchior Sante Animale
Marketing authorisation date:
Manufacturing sites for batch release:
  • Biokema Europe
Responsible authority:
  • Paul-Ehrlich-Institut
Authorisation number:
  • PEI.V.03587.01.1
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 21/10/2025
Download